Condition
Prostate Cancer Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Prostate Cancer Recurrent clinical trials that are recruiting, at sites in 8 countries (most in United States (3), Germany (2), China (1)). By phase: Phase 1/2 (2), Phase 2 (2), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 8Countries
Newest Prostate Cancer Recurrent clinical trials
All recruiting trials (11)
-
How social, structural, and lifestyle factors relate to prostate cancer outcomes in diverse men
This study looks at whether social and lifestyle factors help explain differences in prostate cancer outcomes among Black, Hispanic, and Asian men who have had a radical prostatectomy.
-
Biomarker-guided donor CAR-NK therapy targeting one or two tumor antigens for advanced solid tumors
This treatment tries donor-derived CAR-NK cells that target one or two tumor antigens for adults with advanced solid tumors such as breast, NSCLC, colorectal, and recurrent prostate cancer.
-
Immune biomarker testing for men receiving prostate brachytherapy
This project will test how immune cells in blood and tumor tissue change before, during, and after brachytherapy in men treated for prostate cancer.
-
Mini-tumors to guide treatment for aggressive prostate cancer
We will grow tiny, patient-derived mini-tumors in the lab to test which treatments work best for men with aggressive or metastatic prostate cancer.
-
Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy
This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.
-
High-Dose-Rate Brachytherapy for Prostate Cancer Recurrence
This study is testing a new way to treat prostate cancer that has come back after previous radiation therapy, using a special type of targeted radiation guided by MRI to see if it helps patients feel better and improve their health.
-
Treatment for recurrent prostate cancer using PSMA radioligand therapy
This study is testing a new treatment for men with recurrent prostate cancer to see if a special therapy can help slow down the disease after their PSA levels have risen.
-
Using antibody CC-1 to treat men with recurrent prostate cancer
This study is testing a new antibody treatment called CC-1 to see if it can safely help men with recurrent prostate cancer.
-
Treatment for recurrent prostate cancer with metastases
This study is testing whether combining hormone therapy with targeted radiation or surgery can help men with recurrent prostate cancer live longer without their cancer spreading.
-
Combination therapy for advanced solid tumors and prostate cancer
This study is testing a new combination of five oral drugs to see if they can safely help people with advanced solid tumors and prostate cancer.
-
Evaluating PSMA-PET/CT for Prostate Cancer Recurrence
This study is testing if using a special imaging technique called PSMA-PET/CT can help guide better treatment for men with prostate cancer who have had a rise in their PSA levels after surgery.
Related topics
Quick answers
How many Prostate Cancer Recurrent clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), Germany (2 trials), China (1 trial), Canada (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 2, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.